Oisin Biotechnologies
About:
Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.
Website: https://www.oisinbio.com
Top Investors: AbbVie, Hedgewood, KIZOO Technology Capital, Avant Global, Kingsley Advani
Description:
Oisin Biotechnologies is a platform drug development company focused on creating drugs to combat a variety of age-related diseases. It is developing a highly precise, patent-pending, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces the negative effects of aging pathologies and also extends the median lifespan and survival. Oisin Biotechnologies was founded in 2014 and is headquartered in Seattle, Washington.
$22.1M
$1M to $10M
Seattle, Washington, United States
2014-01-01
Garry Hudson, Kevin Perrott, Matthew Scholz
11-50
2024-07-24
Private
© 2025 bioDAO.ai